The latest in the hantavirus cruise ship saga, why these former officials left the FDA, and more health news from Morning ...

Increasing the number of men in nursing could benefit patients by strengthening care team dynamics. Gender-diverse teams have ...

Scientists are worried that hantaviruses haven’t been as well studied as they ought to be, but not that the MV Hondius cruise ...

The WHO held a press conference about the situation Thursday. Here are five key takeaways: At present no one who is ill is ...

Most researchers conduct their more disruptive work early in their careers, but as they age, they tend to abandon that ...

Fabricated” citations that do not reference real academic papers are spreading in the literature, polluting the public record ...

The retirement of Luis Rodríguez, who has been part of the Vessel Sanitation Program since 2010 and served as its chief since ...

Sanofi asked the FDA to pull teplizumab out of a speedy review voucher program after a political appointee disagreed with ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

Also, FDA leadership is facing fresh accusations of political interference in drug reviews, AI oncology startups are trying to make cancer care virtual, and scientists are opening up an entirely new ...

The White House nods to medication-assisted treatment and fentanyl test strips, despite recently placing new limits.

A political appointee gets in the way of a Sanofi drug's approval, and more from STAT's D.C. Diagnosis newsletter.